Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Hepatitis

Free Subscription Articles published in Transplantation Retrieve available abstracts of 69 articles: HTML format

Single Articles

May 2021
1. MUTHUKUMAR T, Akat KM, Yang H, Schwartz JE, et al
   Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study.
   Transplantation. 2021 May 11. pii: 00007890-900000000-95253.
   PubMed     Abstract available
   
   
   February 2021
2. CALABRESE DR
   Ribavirin to the Rescue: Natural Killer Cell Function After Hepatitis C Virus Treatment in Liver Transplant Recipients.
   Transplantation. 2021 Feb 12. pii: 00007890-900000000-95359.
   PubMed    
   
   
   
3. YOELI D, Choudhury RA, Moore HB, Sauaia A, et al
   Are Hepatitis C Positive Female Liver Transplant Recipients Still at Increased Risk for Graft Failure? Re-Examining the Disparity in the Modern Era of Direct Acting Antiviral Agents.
   Transplantation. 2021 Feb 11. pii: 00007890-900000000-95364.
   PubMed     Abstract available
   
   
   
4. HUCKABY LV, Seese LM, Handzel R, Wang Y, et al
   Center-level Utilization of Hepatitis C Virus Positive Donors for Orthotopic Heart Transplantation.
   Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003674.
   PubMed     Abstract available
   
   
   January 2021
5. FUJISAKI T, Mikami T, Kuno T, Moss N, et al
   Effect of Hepatitis C Virus Infection on Heart Transplants in the Current Era.
   Transplantation. 2021 Jan 25. pii: 00007890-900000000-95404.
   PubMed     Abstract available
   
   
   November 2020
6. BIAN X, Fan X, Wang Y
   Influence of Asymptomatic Carriers With COVID-19 on Transplantation Resumption in Wuhan.
   Transplantation. 2020;104:e328.
   PubMed    
   
   
   October 2020
7. NGUYEN T, Sise ME, Delgado C, Williams W, et al
   Race, Education, and Gender Disparities in Transplantation of Kidneys from Hepatitis C Viremic Donors.
   Transplantation. 2020 Oct 29. doi: 10.1097/TP.0000000000003511.
   PubMed     Abstract available
   
   
   August 2020
8. FALLAHZADEH MA, Trotter JF
   An Experiment of Nature: HBV-naive Recipients Receiving Liver Grafts With HBV Core Antibody-positive Donors Without Antiviral Prophylaxis.
   Transplantation. 2020;104:e245-e246.
   PubMed    
   
   
   June 2020
9. COTTER TG, Aronsohn A, Reddy KG, Charlton M, et al
   Liver Transplantation of HCV-Viremic Donors into HCV-Negative Recipients in the USA: Increasing Frequency with Profound Geographic Variation.
   Transplantation. 2020 Jun 29. doi: 10.1097/TP.0000000000003382.
   PubMed     Abstract available
   
   
   
10. BAE S, Durand CM, Garonzik-Wang JM, Chow EKH, et al
    Antithymocyte Globulin Versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients With Hepatitis C Virus.
    Transplantation. 2020;104:1294-1303.
    PubMed     Abstract available
    
    
    March 2020
11. HENSON JB, Wilder JM, Kappus MR, Barbas AS, et al
    Transplant Outcomes in Older Patients with Nonalcoholic Steatohepatitis Compared to Alcohol-Related Liver Disease and Hepatitis C.
    Transplantation. 2020 Mar 6. doi: 10.1097/TP.0000000000003219.
    PubMed     Abstract available
    
    
    January 2020
12. GORGEN A, Galvin Z, Huang AC, Vinaixa C, et al
    The Impact of Direct Acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.: An International Multicenter Study.
    Transplantation. 2020 Jan 16. doi: 10.1097/TP.0000000000003115.
    PubMed     Abstract available
    
    
    November 2019
13. KAHN J, Terrault NA
    Intentional Transmission of Hepatitis C With Organ Transplantation: With Opportunity Comes Responsibility.
    Transplantation. 2019;103:2215-2216.
    PubMed    
    
    
    October 2019
14. BURTON JR JR, Terrault NA, Goldberg DS, Bloom RD, et al
    Liver and Kidney Recipient Selection of HCV-Viremic Donors - Meeting Consensus Report from the 2019 Controversies in Transplantation.
    Transplantation. 2019 Oct 18. doi: 10.1097/TP.0000000000003014.
    PubMed     Abstract available
    
    
    September 2019
15. BAE S, Durand CM, Garonzik-Wang JM, Chow EKH, et al
    Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus.
    Transplantation. 2019 Sep 13. doi: 10.1097/TP.0000000000002959.
    PubMed     Abstract available
    
    
    
16. CANNON RM, Locke JE, Orandi BJ, Anderson DJ, et al
    Impact of donor hepatitis C virus on kidney transplant outcomes for hepatitis C positive recipients in the direct acting antiviral era: time to revise the kidney donor risk index?
    Transplantation. 2019 Sep 9. doi: 10.1097/TP.0000000000002949.
    PubMed     Abstract available
    
    
    
17. HUANG E
    Hepatitis C Infection in Kidney Donors: A Call to Re-examine its Relevance as a Predictor of Transplant Outcomes.
    Transplantation. 2019 Sep 3. doi: 10.1097/TP.0000000000002950.
    PubMed    
    
    
    June 2019
18. GARDINER A, Liu K, Bonnichsen M, Joshi V, et al
    Immunity to vaccine-preventable viral infections in Australians being evaluated for liver transplantation.
    Transplantation. 2019 Jun 28. doi: 10.1097/TP.0000000000002722.
    PubMed     Abstract available
    
    
    May 2019
19. OWADA Y, Oshiro Y, Inagaki Y, Harada H, et al
    A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan.
    Transplantation. 2019 May 20. doi: 10.1097/TP.0000000000002801.
    PubMed     Abstract available
    
    
    March 2019
20. DI GIORGIO A, Nicastro E, Dalla Rosa D, Nebbia G, et al
    Transplant-free Survival in Chronic Liver Disease Presenting as Acute Liver Failure in Childhood.
    Transplantation. 2019;103:544-551.
    PubMed     Abstract available
    
    
    February 2019
21. EKSER B, Chen AM, Kubal CA, Fridell JA, et al
    DELAYED KIDNEY TRANSPLANTATION AFTER 83 HOURS OF COLD ISCHEMIA TIME IN COMBINED LIVER-KIDNEY TRANSPLANT.
    Transplantation. 2019 Feb 14. doi: 10.1097/TP.0000000000002673.
    PubMed    
    
    
    October 2018
22. CHARLTON MR, Gane EJ, Shukla A, Dashtseren B, et al
    International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting - From Noncirrhotic to Decompensated Disease and Following Liver Transplantation.
    Transplantation. 2018 Oct 17. doi: 10.1097/TP.0000000000002453.
    PubMed     Abstract available
    
    
    
23. 
    Successful Treatment of Chronic Hepatitis C Virus Infection with Sofosbuvir and Ledipasvir in Renal Transplant Recipients: Erratum.
    Transplantation. 2018;102:e458.
    PubMed    
    
    
    September 2018
24. CROOME KP, Mathur AK, Pungpapong S, Lee DD, et al
    Equivalent Outcomes with Retransplantation and Primary Liver Transplantation in the Direct Acting Antiviral Era.
    Transplantation. 2018 Sep 21. doi: 10.1097/TP.0000000000002460.
    PubMed     Abstract available
    
    
    July 2018
25. GADSDEN MM, Goldberg DS
    Hepatic Dysfunction in Deceased Donors in the Age of the Opioid Epidemic.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002368.
    PubMed    
    
    
    
26. THULUVATH PJ, Hanish S, Savva Y
    Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared to Cryptogenic, Alcoholic or AIH Cirrhosis.
    Transplantation. 2018 Jul 5. doi: 10.1097/TP.0000000000002355.
    PubMed     Abstract available
    
    
    
27. GONZALEZ-DIEGUEZ ML, Vidal DV, Mendoza Pacas GE, Houghton RF, et al
    TACROLIMUS INDUCED CHOLESTATIC HEPATITIS IN A PATIENT WITH LIVER TRANSPLANT.
    Transplantation. 2018 Jul 3. doi: 10.1097/TP.0000000000002332.
    PubMed    
    
    
    
28. SAGESHIMA J, Troppmann C, McVicar JP, Santhanakrishnan C, et al
    Impact of Willingness to Accept Hepatitis C Seropositive Kidneys Among Hepatitis C RNA-Positive Waitlisted Patients.
    Transplantation. 2018;102:1179-1187.
    PubMed     Abstract available
    
    
    
29. ANKCORN MJ, Ijaz S, Poh J, Elsharkawy AM, et al
    Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients.
    Transplantation. 2018;102:1139-1147.
    PubMed     Abstract available
    
    
    June 2018
30. BOWRING MG, Kucirka LM, Massie AB, Ishaque T, et al
    Changes in utilization and discard of HCV-antibody positive deceased-donor kidneys in the era of direct-acting antiviral therapy.
    Transplantation. 2018 Jun 13. doi: 10.1097/TP.0000000000002323.
    PubMed     Abstract available
    
    
    May 2018
31. TUCCI A, Rizza S, Cocchis D, Martini S, et al
    Early and late hepatitis B reactivation following IFN- or DAA-based therapy of recurrent hepatitis C in anti-HBc-positive liver transplant recipients.
    Transplantation. 2018 May 2. doi: 10.1097/TP.0000000000002241.
    PubMed    
    
    
    April 2018
32. JEON JW, Kim SM, Cho H, Baek CH, et al
    Presence of hepatitis B surface antibody in addition to hepatitis B core antibody confers protection against hepatitis B virus infection in hepatitis B surface antigen-negative patients undergoing kidney transplantation.
    Transplantation. 2018 Apr 5. doi: 10.1097/TP.0000000000002173.
    PubMed     Abstract available
    
    
    March 2018
33. MALLET V, Sberro-Soussan R, Roque-Afonso AM, Vallet-Pichard A, et al
    Transmission of hepatitis E virus with plasma exchange in kidney-transplant recipients: a retrospective cohort study.
    Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002185.
    PubMed     Abstract available
    
    
    
34. WEDEMEYER H
    E-xchange: Hepatitis E and the risk of plasma products for organ transplant recipients.
    Transplantation. 2018 Mar 20. doi: 10.1097/TP.0000000000002186.
    PubMed    
    
    
    February 2018
35. VIONNET J, Yerly P, Aubert JD, Pascual M, et al
    Management of severe portopulmonary hypertension with dual oral therapy prior to liver transplantation.
    Transplantation. 2018 Feb 26. doi: 10.1097/TP.0000000000002142.
    PubMed    
    
    
    
36. FARIA LC, Terrabuio DRB, Leblebicioglu H, Huprikar S, et al
    Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors.
    Transplantation. 2018;102.
    PubMed    
    
    
    
37. DI MAIRA T, Torregrosa A, Navarro V, Sanchez D, et al
    Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment.
    Transplantation. 2018;102:e74-e81.
    PubMed     Abstract available
    
    
    January 2018
38. MCCAULEY M, Mussell A, Goldberg D, Sawinski D, et al
    Race, Risk, and Willingness of End-stage Renal Disease Patients Without Hepatitis C (HCV) to Accept an HCV-infected Kidney Transplant.
    Transplantation. 2018 Jan 18. doi: 10.1097/TP.0000000000002099.
    PubMed     Abstract available
    
    
    
39. LIM MA, Kamili S, Cohen J, Green-Montfort T, et al
    Hepatitis E Virus Infection in Kidney Transplant Patients: A Single-center Study.
    Transplantation. 2018 Jan 11. doi: 10.1097/TP.0000000000002071.
    PubMed    
    
    
    December 2017
40. THULUVATH PJ, Hanish S, Savva Y
    Liver Transplantation in Cryptogenic Cirrhosis: Outcome comparisons between NASH, Alcoholic and AIH cirrhosis.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002030.
    PubMed     Abstract available
    
    
    November 2017
41. TROTTER PB, Summers DM, Ushiro-Lumb I, Robb M, et al
    Use of organs from hepatitis C virus positive donors for uninfected recipients: a potential cost-effective approach to save lives?
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002033.
    PubMed     Abstract available
    
    
    
42. AGARWAL N, Davis RJ, Gracey DM, Wong G, et al
    Detection of Hepatitis C antibodies without viral transmission in Hepatitis C negative recipients receiving kidneys from Hepatitis C positive donors treated with Direct Acting Anti-Viral Therapy.
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002034.
    PubMed    
    
    
    
43. HOLSCHER CM, Durand CM, Desai NM
    Expanding the Use of Organs from Hepatitis C-Viremic Donors: The Evidence Continues to Build.
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002032.
    PubMed    
    
    
    
44. KAMAR N, Del Bello A, Izopet J
    Should persistent hepatitis E virus replication in transplant patients be tolerated?
    Transplantation. 2017 Nov 10. doi: 10.1097/TP.0000000000001994.
    PubMed    
    
    
    October 2017
45. HEO NY, Mannalithara A, Kim D, Udompap P, et al
    Long-term Patient and Graft Survival of Kidney Transplant Recipients with Hepatitis C Virus Infection in the United States.
    Transplantation. 2017 Oct 3. doi: 10.1097/TP.0000000000001953.
    PubMed     Abstract available
    
    
    September 2017
46. RADHAKRISHNAN K, Chi A, Quan DJ, Roberts JP, et al
    Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
    Transplantation. 2017;101:2079-2082.
    PubMed     Abstract available
    
    
    August 2017
47. ANTONINI TM, Coilly A, Rossignol E, Fougerou-Leurent C, et al
    Sofosbuvir-based Regimens in HIV/HCV Coinfected Patients after Liver Transplantation: Results from the ANRS CO23 CUPILT Study.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001928.
    PubMed     Abstract available
    
    
    
48. CHOLANKERIL G, Li AA, Yoo ER, Ahmed A, et al
    Direct-Acting Antiviral Therapy and Improvement in Graft Survival of Hepatitis C Liver Transplant Recipients.
    Transplantation. 2017 Aug 24. doi: 10.1097/TP.0000000000001926.
    PubMed    
    
    
    
49. GARCIA CR, Acosta LF, Mei X, Berger J, et al
    Liver Transplantation for the Treatment of Complicated Iatrogenic Biliary Injuries: A National Review from the UNOS Dataset.
    Transplantation. 2017 Aug 22. doi: 10.1097/TP.0000000000001922.
    PubMed     Abstract available
    
    
    
50. ABAALKHAIL F, Elsiesy H, Elbeshbeshy H, Shawkat M, et al
    Treatment of Patients With Hepatitis C Virus infection (Genotype 4) With Ledipasvir-Sofosbuvir in the Liver Transplant Setting.
    Transplantation. 2017 Aug 9. doi: 10.1097/TP.0000000000001907.
    PubMed     Abstract available
    
    
    
51. MCPHERSON S, Elsharkawy AM, Ankcorn M, Ijaz S, et al
    Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation.
    Transplantation. 2017 Aug 9. doi: 10.1097/TP.0000000000001908.
    PubMed     Abstract available
    
    
    July 2017
52. FUNG J, Wong T, Chok K, Chan A, et al
    Oral nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B with Preexisting rt204 Mutation.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001883.
    PubMed     Abstract available
    
    
    
53. WALLER KMJ, Wyburn KR, Shackel NA, O'Leary MJ, et al
    Hepatitis transmission risk in kidney transplantation (the HINT study): a cross-sectional survey of transplant clinicians in Australian and New Zealand.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001885.
    PubMed     Abstract available
    
    
    
54. PRUETT TL, Clark MA, Taranto SE
    Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Transplantation. 2017;101:1670-1678.
    PubMed     Abstract available
    
    
    
55. VOLK ML, Wilk AR, Wolfe C, Kaul DR, et al
    The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year.
    Transplantation. 2017;101:1666-1669.
    PubMed     Abstract available
    
    
    June 2017
56. MASUTANI K, Omoto K, Okumi M, Okabe Y, et al
    Incidence of Hepatitis B Viral Reactivation After Kidney Transplantation With Low-dose Rituximab Administration.
    Transplantation. 2017 Jun 29. doi: 10.1097/TP.0000000000001870.
    PubMed     Abstract available
    
    
    May 2017
57. 
    Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study: Erratum.
    Transplantation. 2017;101:e193.
    PubMed    
    
    
    
58. SINGH N, Dies D, Samant H
    Hepatitis C-Positive Kidney Transplant Recipients-When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
    Transplantation. 2017;101:e192.
    PubMed    
    
    
    
59. TERRAULT NA, Berenguer M, Strasser SI, Gadano A, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
    Transplantation. 2017;101:956-967.
    PubMed    
    
    
    
60. TERRAULT NA, McCaughan GW, Curry MP, Gane E, et al
    International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
    Transplantation. 2017;101:945-955.
    PubMed    
    
    
    
61. TAPPER EB, Afdhal NH, Curry MP
    Before or After Transplantation? A Review of the Cost Effectiveness of Treating Waitlisted Patients With Hepatitis C.
    Transplantation. 2017;101:933-937.
    PubMed     Abstract available
    
    
    April 2017
62. MAZZOLA A, Minh MT, Charlotte F, Hdjii A, et al
    Chronic hepatitis E viral infection after liver transplantation: a regression of fibrosis following antiviral therapy.
    Transplantation. 2017 Apr 4. doi: 10.1097/TP.0000000000001766.
    PubMed     Abstract available
    
    
    
63. MARTIN MT, Koppe S
    Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on Hemodialysis.
    Transplantation. 2017 Apr 3. doi: 10.1097/TP.0000000000001758.
    PubMed     Abstract available
    
    
    February 2017
64. SANTOS AH JR, Casey MJ, Xuerong W, Womer KL, et al
    Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes: A 14-Year Registry-Based Cohort Study in the United States.
    Transplantation. 2017;101:377-386.
    PubMed     Abstract available
    
    
    January 2017
65. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Abstract available
    
    
    December 2016
66. CROOME KP, Lee DD, Keaveny AP, Taner CB, et al
    Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors.
    Transplantation. 2016;100:2640-2647.
    PubMed     Abstract available
    
    
    November 2016
67. BARBIER L, Cesaretti M, Dondero F, Cauchy F, et al
    Liver Transplantation With Older Donors: A Comparison With Younger Donors in a Context of Organ Shortage.
    Transplantation. 2016;100:2410-2415.
    PubMed     Abstract available
    
    
    April 2016
68. BRAUN HJ, Dodge JL, Roll GR, Freise CE, et al
    Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Abstract available
    
    
    March 2016
69. ADDOLORATO G, Bataller R, Burra P, DiMartini A, et al
    Liver Transplantation for Alcoholic Liver Disease.
    Transplantation. 2016.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: